BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10762168)

  • 1. A single nucleotide polymorphism of dopamine transporter gene is associated with Parkinson's disease.
    Morino H; Kawarai T; Izumi Y; Kazuta T; Oda M; Komure O; Udaka F; Kameyama M; Nakamura S; Kawakami H
    Ann Neurol; 2000 Apr; 47(4):528-31. PubMed ID: 10762168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between dopamine transporter gene polymorphism and susceptibility to Parkinson's disease in Japan.
    Nishimura M; Kaji R; Ohta M; Mizuta I; Kuno S
    Mov Disord; 2002 Jul; 17(4):831-2. PubMed ID: 12210886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
    Le Couteur DG; Leighton PW; McCann SJ; Pond Sm
    Mov Disord; 1997 Sep; 12(5):760-3. PubMed ID: 9380062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association study of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers.
    Jeong SH; Joo EJ; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):975-83. PubMed ID: 15380858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Association between genetic polymorphism of dopamine transporter gene and susceptibility to Parkinson's disease].
    Wang J; Liu Z; Chen B
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):346-8. PubMed ID: 11798784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between dopamine transporter gene polymorphism and Parkinson's disease].
    Zhang L; Shao M; Xu Q; Dong X; Yang J; Li Y; Chen B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Dec; 18(6):431-4. PubMed ID: 11774209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cloned dopamine transporter. Potential insights into Parkinson's disease pathogenesis.
    Uhl GR; Kitayama S
    Adv Neurol; 1993; 60():321-4. PubMed ID: 8380524
    [No Abstract]   [Full Text] [Related]  

  • 8. Segmental linkage disequilibrium within the dopamine transporter gene.
    Greenwood TA; Alexander M; Keck PE; McElroy S; Sadovnick AD; Remick RA; Shaw SH; Kelsoe JR
    Mol Psychiatry; 2002; 7(2):165-73. PubMed ID: 11840309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA sequence analysis of monoamine oxidase B gene coding and promoter regions in Parkinson's disease cases and unrelated controls.
    Costa-Mallen P; Afsharinejad Z; Kelada SN; Costa LG; Franklin GM; Swanson PD; Longstreth WT; Viernes HM; Farin FM; Smith-Weller T; Checkoway H
    Mov Disord; 2004 Jan; 19(1):76-83. PubMed ID: 14743364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.
    Mössner R; Henneberg A; Schmitt A; Syagailo YV; Grässle M; Hennig T; Simantov R; Gerlach M; Riederer P; Lesch KP
    Mol Psychiatry; 2001 May; 6(3):350-2. PubMed ID: 11326308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter: basic science and human variation of a key molecule for dopaminergic function, locomotion, and parkinsonism.
    Uhl GR
    Mov Disord; 2003 Oct; 18 Suppl 7():S71-80. PubMed ID: 14531049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease.
    Paus S; Seeger G; Brecht HM; Köster J; El-Faddagh M; Nöthen MM; Klockgether T; Wüllner U
    Mov Disord; 2004 Jun; 19(6):705-7. PubMed ID: 15197713
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple regions of alpha-synuclein are associated with Parkinson's disease.
    Mueller JC; Fuchs J; Hofer A; Zimprich A; Lichtner P; Illig T; Berg D; Wüllner U; Meitinger T; Gasser T
    Ann Neurol; 2005 Apr; 57(4):535-41. PubMed ID: 15786467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence alterations in the reduced folate carrier are observed in osteosarcoma tumor samples.
    Yang R; Sowers R; Mazza B; Healey JH; Huvos A; Grier H; Bernstein M; Beardsley GP; Krailo MD; Devidas M; Bertino JR; Meyers PA; Gorlick R
    Clin Cancer Res; 2003 Feb; 9(2):837-44. PubMed ID: 12576457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exon/intron boundaries, novel polymorphisms, and association analysis with schizophrenia of the human synaptic vesicle monoamine transporter (SVMT) gene.
    Kunugi H; Ishida S; Akahane A; Nanko S
    Mol Psychiatry; 2001 Jul; 6(4):456-60. PubMed ID: 11443533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-control study of dopamine transporter-1, monoamine oxidase-B, and catechol-O-methyl transferase polymorphisms in Parkinson's disease.
    Goudreau JL; Maraganore DM; Farrer MJ; Lesnick TG; Singleton AB; Bower JH; Hardy JA; Rocca WA
    Mov Disord; 2002 Nov; 17(6):1305-11. PubMed ID: 12465073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence of association between a dopamine transporter gene polymorphism (1215A/G) and Parkinson's disease.
    Kimura M; Matsushita S; Arai H; Takeda A; Higuchi S
    Ann Neurol; 2001 Feb; 49(2):276-7. PubMed ID: 11220753
    [No Abstract]   [Full Text] [Related]  

  • 18. Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.
    Grimes DA; Han F; Panisset M; Racacho L; Xiao F; Zou R; Westaff K; Bulman DE
    Mov Disord; 2006 Jul; 21(7):906-9. PubMed ID: 16532445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single photon emission computer tomography of dopamine transporters in monkeys and humans with 99mTc-TRODAT-1.
    Hu P; Chen L; Zhang HQ; Li JR; Liang H
    Chin Med J (Engl); 2004 Jul; 117(7):1056-9. PubMed ID: 15265382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward identification of susceptibility genes for sporadic Parkinson's disease.
    Toda T; Momose Y; Murata M; Tamiya G; Yamamoto M; Hattori N; Inoko H
    J Neurol; 2003 Oct; 250 Suppl 3():III40-3. PubMed ID: 14579123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.